Gene, Cell and Tissue

Published by: Kowsar

Cause or Effect: Which Genetic Changes Are Associated With Cancer?

David J. Timson 1 , 2 , *
Author Information
1 Medical Biology Center, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom
2 Institute for Global Food Security, Queen’s University Belfast, Belfast, United Kingdom
Article information
  • Gene, Cell and Tissue: November 01, 2014, 1 (3); e23818
  • Published Online: October 22, 2014
  • Article Type: Letter
  • Received: September 22, 2014
  • Accepted: September 28, 2014
  • DOI: 10.17795/gct-23818

To Cite: J. Timson D. Cause or Effect: Which Genetic Changes Are Associated With Cancer?, Gene Cell Tissue. 2014 ; 1(3):e23818. doi: 10.17795/gct-23818.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnote
References
  • 1. Lorente D, De Bono JS. Molecular alterations and emerging targets in castration resistant prostate cancer. Eur J Cancer. 2014; 50(4): 753-64[DOI][PubMed]
  • 2. Gaya JM, Ahallal Y, Sanchez-Salas R, Barret E, Rozet F, Galiano M, et al. Current, new and novel therapy for castration-resistant prostate cancer. Expert Rev Anticancer Ther. 2013; 13(7): 819-27[DOI][PubMed]
  • 3. Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014; 1(2)
  • 4. Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, et al. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate. 2007; 67(8): 849-54[DOI][PubMed]
  • 5. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002; 32(4): 581-3[DOI][PubMed]
  • 6. Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003; 42(7): 1805-12[DOI][PubMed]
  • 7. Elliott SF, Allen G, Timson DJ. Biochemical analysis of the interactions of IQGAP1 C-terminal domain with CDC42. World J Biol Chem. 2012; 3(3): 53-60[DOI][PubMed]
  • 8. Pey AL, Megarity CF, Timson DJ. FAD binding overcomes defects in activity and stability displayed by cancer-associated variants of human NQO1. Biochim Biophys Acta. 2014; 1842(11): 2163-73[DOI][PubMed]
  • 9. Lienhart WD, Gudipati V, Uhl MK, Binter A, A. Pulido S , Saf R, et al. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase. FEBS J. 2014; 281(20): 4691-704[DOI][PubMed]
  • 10. Ringe D, Petsko GA. What are pharmacological chaperones and why are they interesting? J Biol. 2009; 8(9): 80[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments